What are the information sources for the Biomarkers content?
Principal information sources are biomedical literature and congresses, clinicaltrials.gov, the FDA website and patent literature ( WO, US, EP and JP). Work is underway to expand coverage to include press releases and other information from company websites. The main sources are: • Scientific meetings: Information is taken from meetings that specialize in biomarkers content (such as World Biomarkers Summit) as well as relevant meetings in all therapeutic areas where data related to biomarkers can also be presented (ASCO, ACCR, ADA, AUA, etc) • Literature Information: References are identified by searching MEDLINE® and full-text of peer reviewed journals included in the Web of Science. Guidelines from scientific societies are usually included here. • Patents: From four patent authorities: Japan Patent Office (JP), World Intellectual Property Organization (WIPO), US Patents & Trademark Office (US) and European Patent Office (EP).
